• $3.6M
    Market Cap
  • -78.57%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-454,000
+304.14%
-112,337
-90.22%
-1.1M
+17.53%
-977,768
-51.45%
Depreciation and Amortization Expense
11,544
+45.21%
7,950
-4.04%
8,285
+127.36%
3,644
N/A
Total Operating Expenses
1.8M
-17.12%
2.2M
-41.50%
3.8M
+78.07%
2.1M
-49.36%
Operating Profit
-1.8M
-17.12%
-2.2M
-41.50%
-3.8M
+78.07%
-2.1M
-49.36%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-2.0M
+753.98%
Interest Income and Expense and Net
0
N/A
0
N/A
0
+100.00%
-2.0M
+753.98%
Total Nonoperating Income and Expense
-280,568
+78.78%
-156,937
-79.42%
-762,571
+45.75%
-523,192
+66.83%
Income before Taxes
-2.1M
-10.80%
-2.4M
-47.84%
-4.6M
+71.71%
-2.7M
-41.31%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
0
N/A
0
N/A
0
N/A
0
N/A
Net Income
-2.1M
-10.29%
-2.4M
-47.08%
-4.5M
+81.52%
-2.5M
-45.59%
Net Income from Continuing Operations Applicable to Common
-2.1M
-10.80%
-2.4M
-47.84%
-4.6M
+71.71%
-2.7M
-34.09%
Basic EPS and Net Income
-0.02
0.00%
-0.02
-33.33%
-0.03
+50.00%
-0.02
-50.00%
Diluted EPS and Net Income
-0.02
0.00%
-0.02
-33.33%
-0.03
+50.00%
-0.02
-50.00%
Basic Weighted Average Shares
91.8M
-33.73%
138.6M
+3.45%
134.0M
+16.36%
115.1M
+8.36%
Diluted Weighted Average Shares
91.8M
-33.73%
138.6M
+3.45%
134.0M
+16.36%
115.1M
+8.36%
Balance Sheet
Cash and Cash Equivalents
509,914
+9,793.56%
5,154
-80.24%
26,086
-91.17%
295,401
+308.25%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
509,914
+9,793.56%
5,154
-80.24%
26,086
-91.17%
295,401
+308.25%
Total Current Assets
513,465
+9,862.46%
5,154
-80.24%
26,086
-91.17%
295,401
+308.25%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
658,552
+374.82%
138,694
-0.49%
139,382
-62.42%
370,936
+210.95%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
1.3M
+332.64%
289,078
-84.98%
1.9M
-11.09%
2.2M
+2.02%
Total Current Liabilities
3.2M
+68.33%
1.9M
-40.49%
3.2M
-11.44%
3.7M
+11.78%
Total Long-Term Debt
1.1M
-64.75%
3.1M
-27.67%
4.2M
-7.65%
4.6M
+116.72%
Total Long-Term Liabilities
62,400
-66.57%
186,652
N/A
N/A
N/A
N/A
N/A
Total Liabilities
3.2M
+68.33%
1.9M
-40.49%
3.2M
-11.44%
3.7M
+11.78%
Retained Earnings
-21.0M
+11.22%
-18.9M
+20.52%
-15.7M
+39.95%
-11.2M
+28.15%
Total Stockholders Equity
N/A
N/A
N/A
N/A
-3.1M
-5.70%
-3.3M
+4.25%
Total Shares Outstanding
108.1M
+24.62%
86.8M
-40.00%
144.6M
+17.35%
123.3M
+11.20%
Cash Flow
Cash from Operating Activities
-526,455
+844.53%
-55,737
-92.81%
-775,375
-57.06%
-1.8M
+6.38%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-23,091
-18.10%
-28,195
-36.36%
-44,301
+37.38%
-32,247
-12.68%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.1M
+1,573.50%
63,000
-88.55%
550,361
-73.30%
2.1M
+16.77%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-532.60%
-68.71%
-1,702.18%
-2.89%
-1,752.84%
+74.37%
-1,005.22%
-50.53%
Return on Equity
N/A
N/A
N/A
N/A
139.82%
+83.03%
76.39%
-56.98%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.16
+5,751.85%
0.003
-66.25%
0.008
-90.07%
0.08
+264.71%
Cash Ratio
0.16
+5,711.11%
0.003
-66.25%
0.008
-90.07%
0.08
+264.71%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
-1.99
-3.23%
-2.05
+52.87%
Debt-to-Assets Ratio
3.54
-85.38%
24.24
-45.27%
44.28
+142.85%
18.24
-48.75%

Earnings & Revenue History

Debt-to-Assets

Cash Flow